Company: AZN
Filing Date: 2025-09-17
Form Type: 6-K
Source: 0001654954-25-010845
Chunk: 5

Company: ASTRAZENECA PLC
Filing Date: 2025-09-17
Form: 6-K
Chunk 5
---
 disease (COPD) exacerbations.

<div align='center'>SIGNATURES</div>

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

| AstraZeneca 
 PLC         |

Date:17 September 2025

| By: /s/           
 Matthew Bowden    |
| Name:             
 Matthew Bowden    |
| Title:            
 Company Secretary |